Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adverse Effect of Drug Therapy Metabolism Medications (Diagnosis)”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableStudy completedNCT02191358
What this trial is testing

YouScript IMPACT Registry

Who this might be right for
Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more
Genelex Corporation 800
Very early researchStudy completedNCT03420469
What this trial is testing

Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers

Who this might be right for
Adverse Effect of Drug Therapy Metabolism Medications (Diagnosis)
Indiana University 28
Not applicableLooking for participantsNCT07183579
What this trial is testing

Effective Dosing of Burosumab in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
University of Nottingham 120
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Not applicableUnknownNCT00437775
What this trial is testing

ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects

Who this might be right for
Diabetes Mellitus Type 2
Assaf-Harofeh Medical Center 300
Early research (Phase 1)Study completedNCT00365781
What this trial is testing

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 10
Post-approval studies (Phase 4)Study completedNCT00224068
What this trial is testing

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Who this might be right for
Anemia
Watson Pharmaceuticals 180
Not applicableStudy completedNCT02428660
What this trial is testing

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

Who this might be right for
Cytochrome P450 CYP2D6 Enzyme DeficiencyPoor Metabolizer Due to Cytochrome P450 CYP2D6 VariantUltrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant+6 more
Genelex Corporation 341
Post-approval studies (Phase 4)Study completedNCT00224042
What this trial is testing

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Who this might be right for
Anemia, Iron-DeficiencyKidney Failure, Chronic
Watson Pharmaceuticals 52
Not applicableLooking for participantsNCT04154553
What this trial is testing

Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure

Who this might be right for
Adverse Drug ReactionTherapy Failure
University Hospital, Basel, Switzerland 400
Not applicableLooking for participantsNCT05951660
What this trial is testing

Sex, Psychopharmacology, and Diabetes

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersDiabetes Mellitus+4 more
Zealand University Hospital 256
Post-approval studies (Phase 4)Ended earlyNCT02638129
What this trial is testing

Naltrexone/Bupropion Cardiovascular Outcomes Study

Who this might be right for
ObesityCardiovascular Diseases
Orexigen Therapeutics, Inc 67